In addition, another study reported increased overall survival and stronger immune responses following a HER-2/neu hybrid polypeptide vaccine in A*24-positive patients [33], corroborating the protective role played by A*24:02 in PCa. This evidence concerns the gene ERBB2 and posterior cortical atrophy.